Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,249 | Dovepress* | 8,107+ | 1,518 | 9,625 | |
PubMed Central* | 1,142 | 422 | 1,564 | ||
Totals | 9,249 | 1,940 | 11,189 | ||
*Since 15 February 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar